Induced pluripotency enables differentiation of human nullipotent embryonal carcinoma cells N2102Ep.

作者: Rujapope Sutiwisesak , Narisorn Kitiyanant , Naiphinich Kotchabhakdi , Gary Felsenfeld , Peter W. Andrews

DOI: 10.1016/J.BBAMCR.2014.07.013

关键词:

摘要: Embryonal carcinoma (EC) cells, which are considered to be malignant counterparts of embryonic stem comprise the pluripotent cell component teratocarcinomas, a form testicular germ tumors (GCTs). Nevertheless, many established human EC lines nullipotent with limited or no capacity differentiate under normal circumstances. In this study, we tested whether an over-expression Yamanaka's reprogramming factors OCT4, SOX2, c-MYC and KLF4 might enable differentiation cells N2102Ep. Using OCT4 knockdown differentiated N2102Ep able derive reprogrammed lines. The induced pluripotency allows toward neural lineage by retinoic acid; expression SSEA3 SSEA4 is down-regulated, whereas that surface markers up-regulated. Consistent up-regulation markers, master neuroectodermal transcription factor PAX6 also in We next investigated induce spontaneous However, while ectopic promotes NTERA2, it induces death nevertheless find upon induction acid, mature neuronal morphology similar NTERA2 as determined TUJ1 expression, absent parental cells. Altogether, conclude state can acquire more relaxed potential factors.

参考文章(47)
B Horvat, Z Gibas, I Damjanov, Retinoic acid-induced differentiation of the developmentally pluripotent human germ cell tumor-derived cell line, NCCIT. Laboratory Investigation. ,vol. 68, pp. 220- 232 ,(1993)
P W Andrews, N C Dracopoli, J Føgh, D Simon, C Carlin, I Damjanov, G S Banting, Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro. Laboratory Investigation. ,vol. 50, pp. 147- 162 ,(1984)
Zhumur Ghosh, Kitchener D. Wilson, Yi Wu, Shijun Hu, Thomas Quertermous, Joseph C. Wu, Persistent Donor Cell Gene Expression among Human Induced Pluripotent Stem Cells Contributes to Differences with Human Embryonic Stem Cells PLoS ONE. ,vol. 5, pp. e8975- ,(2010) , 10.1371/JOURNAL.PONE.0008975
Martin F. Pera, M. J. Blasco Lafita, Judith Mills, Cultured stem-cells from human testicular teratomas: the nature of human embryonal carcinoma, and its comparison with two types of yolk-sac carcinoma. International Journal of Cancer. ,vol. 40, pp. 334- 343 ,(1987) , 10.1002/IJC.2910400309
M.M. Matin, P.W. Andrews, A.R. Bahrami, I. Damjanov, P. Gokhale, J.S. Draper, Embryonic stem (ES) cells and embryonal carcinoma (EC) cells: opposite sides of the same coin. Biochemical Society Transactions. ,vol. 33, pp. 1526- 1530 ,(2005) , 10.1042/BST20051526
Duncan E C Baker, Neil J Harrison, Edna Maltby, Kath Smith, Harry D Moore, Pamela J Shaw, Paul R Heath, Hazel Holden, Peter W Andrews, Adaptation to culture of human embryonic stem cells and oncogenesis in vivo Nature Biotechnology. ,vol. 25, pp. 207- 215 ,(2007) , 10.1038/NBT1285
Jean-Pierre Rousset, Danielle Bucchini, Jacques Jami, Hybrids between F9 nullipotent teratocarcinoma and thymus cells produce multidifferentiated tumors in mice Developmental Biology. ,vol. 96, pp. 331- 336 ,(1983) , 10.1016/0012-1606(83)90170-7
Peter W. Andrews, Peter N. Goodfellow, Lynne H. Shevinsky, David L. Bronson, Barbara B. Knowles, Cell-surface antigens of a clonal human embryonal carcinoma cell line: morphological and antigenic differentiation in culture. International Journal of Cancer. ,vol. 29, pp. 523- 531 ,(1982) , 10.1002/IJC.2910290507